GARFIELD- AF Ambassadors’ Meeting London 21 st October 2016 The GARFIELD-AF registry is funded by an unrestricted research grant from Bayer Pharma AG www.tri-london.ac.uk
GARFIELD-AF Steering Committee Meeting Court Room, Barber- Surgeon’s Hall London 21st October 2016 The GARFIELD-AF registry is funded by an unrestricted research grant from Bayer Pharma AG www.tri-london.ac.uk
Agenda for Steering Committee Title 10:00 Overview of publications and communications Gloria Kayani plan and processes 10:20 Overview of research questions for upcoming papers Professor John Camm 11:00 Discussion: 2017 communications and publications plan All Prioritization of papers for 2017 ESC 2017 Core communication message strategy for 2017 11:40 High-level communication plans for 2018 – 2020 All 12:00 Meeting end www.tri-london.ac.uk
Objectives for today’s meeting • To provide a status update of the publication plan • To discuss the publication planning process and authorship • To agree priorities for papers in 2017 • To agree topics and potential authors for 2017 ESC congress abstracts • To review the broad Communication Messages for 2017 www.tri-london.ac.uk
Overview of publications and communications plan and processes Gloria Kayani Thrombosis Research Institute, UK The GARFIELD-AF registry is funded by an unrestricted research grant from Bayer Pharma AG www.tri-london.ac.uk
www.tri-london.ac.uk
Congress calendar for the next 12 months ISPOR Annual ACC Ambassadors ESC AHA Intl Meeting Washington, Barcelona, Meeting Anaheim, Boston, 17 – 19/03/17 26-30/08/17 11 – 15/11/17 (tbc) 20 – 24/05/17 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec ESC LBS Deadline ESC Deadline Deadline abstract ESC abstract ACC ASH results abstracts results abstracts ASH abstracts Deadline ESC LBS GARFIELD abstracts Symposium Deadline ASH symposium programme www.tri-london.ac.uk
Congress calendar for the next 12 months ACC ISPOR Annual ESC Ambassadors AHA Intl Meeting Washington, Meeting Anaheim, Barcelona, Boston, 11 – 15/11/17 (tbc) 17 – 19 Mar 26-30 Au g 20 – 24/05/17 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec ESC LBS Deadline Deadline Deadline Deadline abstract ACC ASH results abstracts ASH ESC abstracts ESC LBS abstracts abstracts GARFIELD Symposium Deadline ASH symposium programme www.tri-london.ac.uk
GARFIELD-AF publication overview 2016 2017 Anticipated submission J A S O N D J F M A M J Descriptive manuscripts Submitted Treatment patterns Eur Heart J Accepted/published Heart Risk scores Anticipated publication Eur Heart J - QCCO Audit paper Retrospective vs prospective pts NOAC vs VKA* Submission and publication timelines are Patients receiving AP* provisional and subject to change AF registries review *Based on ESC Outcome manuscripts symposium presentations Quality of VKA control PLOS ONE INR in Asia vs other regions Int J Cardiol BMJ open access Gender outcomes Treatment of low-risk patients* Elderly patients CKD ACS patients Early mortality* Optimal INR (time dependent Priority to be confirmed analysis): regional comparison
GARFIELD-AF publication overview 2016 2017 Anticipated submission J A S O N D J F M A M J 2 – 3 per quarter Regional / National Submitted Poland Kardiol Pol Accepted The Netherlands Neth Heart J Anticipated publication Clin Cardiol Regional : LATAM Submission and France publication timelines are Japan provisional and subject to change Regional : Asia BMJ UK
GARFIELD-ORBIT collaboration 2016 2017 J A S O N D J F M A M J GARFIELD-AF scores (validation) Initiation Baseline patient Anticipated submission characteristics Submitted Geographic variations in Anticipated publication event rates Comparative effectiveness Accepted Interim analyses Submission and (Aetion collaboration) publication timelines are provisional and subject Complete analyses to change Statistical methodology Causal /Dynamic models Priority to be confirmed INR data (when, in whom, Priority to be confirmed how much needed?) Prediction models Priority to be confirmed
Manuscripts – GARFIELD-ORBIT collaboration Target Working title Lead Co-authors journal/Congress Fox, Lucas, Pieper, Bassand,Camm, Eur Heart J GARFIELD-AF score: Identifying patients with AF Fitzmaurice, Goldhaber, Goto, Haas, (responding to and "low" thromboembolic risk who are poorly Fox Hacke, Kayani, Oto, Mantovani, reviewers’ characterized by CHA2DS2-VASc Misselwitz, Piccini, Turpie, Verheugt, comments) Kakkar Stats methodology : Prediction models Thomas Pieper, Accetta, Gao TBC Geographical variations in event rates (stroke, Fox Accetta , Darius , Goto , Kayani , TBC major bleeds, mortality) Koretsune , Oh, Parkhomenko, Sawhney , Stepinska , Piccini, Kakkar Global Trends in Use of Oral Anticoagulation for Steinberg Camm, Fox, Gao, Goldhaber, Haas, Kakkar, ACC abstract Patients with Atrial Fibrillation: Results across the Kayani, Piccini, Thomas, Turpie, Verheugt GARFIELD-AF and ORBIT-AF Programs Stats methodology : INR data (when, in whom, Thomas Pieper, Accetta TBC how much needed?) Comparative effectiveness: Causal /Dynamic Thomas Pieper, Accetta, Gao TBC models Comparative effectiveness: Interim analyses Camm, Piccini, Gao ESC Late-breaking abstract? Kakkar Comparative effectiveness : Final analyses TBC Camm, Piccini, GARFIELD-AF steering committee Kakkar www.tri-london.ac.uk
American College of Cardiology Congress (ACC’17) Abstract submission Title Lead Co-authors The prescribing of antiplatelet therapy only in patients with Al Mahmeed, Ambrosio, Angchaisuksiri, Atar, nonvalvular atrial fibrillation: Results from the GARFIELD-AF Verheugt Bassand, Camm, Cools, Eikelboom, Gao, Kayani, Lim, Misselwitz, van Eickels, Kakkar registry Treatment and outcomes of patients with nonvalvular atrial Camm Bassand, Goldhaber, Turpie, Misselwitz, Oh, Van fibrillation according to guideline-defined anticoagulation Eickels, Agnelli, Raatikainen thresholds : Results from the GARFIELD-AF registry Factors determining global trends in the prescribing of Camm, Haas Ambrosio, Kayani, Koretsune, Le Heuzey, vitamin k antagonists (VKA) and non-VKA oral Misselwitz, Parkhomenko, Pieper, Stępińska , van anticoagulants (NOACs) : Results from the GARFIELD-AF Eickels, Kakkar registry Early mortality in newly diagnosed nonvalvular AF Goldhaber Camm, Accetta, Bassand, Fitzmaurice, Goto, Haas, Hacke, Kayani, Misselwitz, Turpie, van Eickels, Verheugt, Kakkar Global Trends in Use of Oral Anticoagulation for Patients Steinberg Gao, Shrader, Pieper, Thomas, Camm, Ezekowitz, with Atrial Fibrillation: Results across the GARFIELD-AF and Fonarow, Gersh, Goldhaber, Haas, Hacke, Kowey, ORBIT-AF Programs Nacarrelli, Reiffel, Turpie, Verheugt, Piccini, Kakkar, Petersen, Fox www.tri-london.ac.uk
GARFIELD-AF: branching out Communications focus for ESC 2016 www.tri-london.ac.uk
Evolution of message Concepts for ESC 2017 e.g. Theme: Holistic approach/ integrated care Global disease burden of AF: The cost of AF Clinical presentation of patients with AF: baseline analysis Hypertension and outcomes Management of elderly/frail and outcomes Management of CKD and outcomes Management of Heart failure and outcomes www.tri-london.ac.uk
PUBLICATIONS PLANNING PROCESSES The GARFIELD-AF registry is funded by an unrestricted research grant from Bayer Pharma AG www.tri-london.ac.uk
www.tri-london.ac.uk
Publications Committee Members • Permanent members: Representatives from the Steering Committee and Thrombosis Research Institute (TRI) A John Camm, London, UK (Chair) Samuel Z Goldhaber, Boston, MA, USA Sylvia Haas, Munich, Germany Gloria Kayani, London, UK • Extended members: Representatives from the Steering Committee and Thrombosis Research Institute (TRI) who participate as needed Jean-Pierre Bassand, Besançon, France Keith AA Fox, Edinburgh, UK Lorenzo G Mantovani, Naples, Italy Karen Pieper, Durham, USA • External experts: Are invited by the Publications Committee, with priority given to National Coordinators and TRI Statisticians www.tri-london.ac.uk
TRI Publications Support Group • Publications Committee is assisted by a publications support group at the TRI, who assist in daily administrative tasks and, when needed o Include roles such as the Lead Garfield-AF Statisticians (Gabriele Accetta and Haiyan Gao) and Garfield-AF Medical Writers (Rae Hobbs and Emily Chu) o Interact with registry investigators and National Coordinators to identify, consolidate, and facilitate publication and presentation opportunities on a national and global level o Responsible for publication plan management www.tri-london.ac.uk
Role of the Publications Committee Develop, in collaboration with the TRI, the GARFIELD-AF Publication Guidelines Define, coordinate, and author the GARFIELD-AF Publication Plan Review, prioritize or reject (if unfeasible or duplicating another project), all GARFIELD-AF publication proposals and manuscripts Liaise with the TRI to facilitate the generation of publications and presentations www.tri-london.ac.uk
Recommend
More recommend
